EX-99.2 7 k71021exv99w2.txt CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 Exhibit 99.2 SECTION 906 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER -------------------------------------------------------------------------------- I, Timothy M. Mayleben, Chief Financial Officer of Esperion Therapeutics, Inc., a Delaware corporation (the "Company"), hereby certify that: (1) The Company's periodic report on Form 10-Q for the period ended June 30, 2002 (the "Form 10-Q") fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934, as amended; and (2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company. * * * /s/ Timothy M. Mayleben --------------------------- Timothy M. Mayleben, Chief Financial Officer Date: August 14, 2002